
Not for use in humans. Keep out of the reach of children.
Adult Human User Safety while handling Animalgesics for Mice & Rats in the laboratory:
Two trained staff for administration: Animalgesics for Mice & Rats should only be handled and administered by laboratory staff trained in the handling of potent opioids. To prevent human adverse reactions or abuse, at least 2 trained administrators should be present during injection of Animalgesics for Mice & Rats.
Protective covering: To prevent direct contact of Animalgesics for Mice & Rats with human skin or mucous membranes when handling the suspension, protective clothing is recommended.
Mucous membrane or eye contact during administration: Direct contact of Animalgesics for Mice & Rats with the eyes, oral or other mucous membranes of humans could result in absorption of buprenorphine and the potential for adverse reactions. If accidental eye, oral or other mucous membrane contact is made during administration, flush the area with water and contact a physician.
Skin contact during administration: If human skin is accidentally exposed to Animalgesics for Mice & Rats, wash the exposed area with soap and water and contact a physician. Accidental exposure could result in absorption of buprenorphine and the potential for adverse reactions.
Drug Abuse, Addiction, and Diversion of Opioids:
Controlled Substance: Animalgesics for Mice & Rats contains buprenorphine, a mu opioid partial agonist and Schedule III controlled substance with an abuse potential similar to other Schedule III opioids. Animalgesics for Mice & Rats can be abused and is subject to misuse, abuse, addiction, and criminal diversion. Animalgesics for Mice & Rats should be handled appropriately to minimize the risk of diversion, including restriction of access, the use of accounting procedures, and proper disposal methods, as appropriate to the laboratory setting and as required by law.
Abuse: Abuse of Animalgesics for Mice & Rats poses a hazard of overdose and death. This risk is increased with concurrent abuse of alcohol and other substances including other opioids and benzodiazepines. Buprenorphine has been diverted for non-medical use into illicit channels of distribution. All people handling opioids require careful monitoring for signs of abuse. Drug abuse is the intentional non-therapeutic use of a prescription drug for its rewarding psychological or physiological effects. Abuse of opioids can occur in the absence of true addiction.
Storage and Discard: Animalgesics for Mice & Rats is a Class III opioid. Store in a locked, substantially constructed cabinet according to DEA and local controlled substance guidelines. Discard broached vials after 28 days. Any unused or expired vials must be destroyed by a DEA registered reverse distributor; for further information, call 1-855-406-7660.
Physician information: Animalgesics for Mice & Rats injectable suspension is a mu opioid partial agonist (1.3 mg buprenorphine/mL). In the case of an emergency, provide the physician with the package insert. Naloxone may not be effective in reversing respiratory depression produced by buprenorphine. The onset of naloxone effect may be delayed by 30 minutes or more. Doxapram hydrochloride has also been used as a respiratory stimulant.
There is currently no manufacturer warning information available for this drug.
There is currently no usage information available for this product. We apologize for any inconvenience.
Animalgesics for Mice & Rats is an injectable suspension of extended-release buprenorphine. Buprenorphine hydrochloride, an opioid analgesic, is the active ingredient in Animalgesics for Mice & Rats. Lipid-bound buprenorphine hydrochloride is suspended in medium chain fatty acid triglyceride (MCT) oil. Lipids encapsulate the buprenorphine limiting diffusion which provides for larger doses and prolonged action.1,2Animalgesics for Mice & Rats has a slightly yellow to white opaque appearance. Each mL contains approximately 1.3 mg buprenorphine hydrochloride. The sterile product contains cholesterol, glyceryl tristearate, and buprenorphine hydrochloride suspended in MCT oil.
Buprenorphine
Formula C29H41NO4
